She has a degree in Medicine from the State University of Rio de Janeiro UERJ (1988), a master’s degree in Medical Science from the Karolinska Institute, Sweden (1987); Fellow Research at Umea University, Sweden (1989-1990) and a doctorate in Cellular and Molecular Biology from the Oswaldo Cruz Foundation (1998). She is a physician-researcher at the National Cancer Institute with experience in Medicine, with emphasis on Hematology and Bone Marrow Transplantation, working mainly on the following topics: Chronic Myeloid Leukemia, BCR-ABLneg Chronic Myeloproliferative Diseases; Acute Myeloid Leukemia; Myelodysplastic Syndrome (SMD) and Acute Lymphoid Leukemia Ph+; Molecular Genetics and molecular alterations in the etiopathogenesis of acute leukemias. Recent initiation in molecular oncology in Gliomas. She was a founding partner of Progenética, one of the first companies in Brazil dedicated to molecular diagnostics. Currently, besides coordinating the laboratory at INCA, she is a consultant for the development and implementation of complex molecular diagnostics.
WHEN 2, 3 and 4 May 2023 WHERE Virtual Platform + Bio-Manguinhos – Fiocruz Rio de Janeiro, RJ